TruAlt Bioenergy IPO began trading on the bourses with a solid performance, listing its shares at ₹545.40 on NSE and ₹550 on BSE, reflecting strong investor sentiment and robust demand during its IPO phase.
TruAlt Bioenergy opened at ₹545.40 per share on NSE, recording a 10% premium over its IPO issue price of ₹496. On the BSE, shares debuted at ₹550, marking an 11% jump. The IPO had set a price band between ₹472 and ₹496, and the offering saw an impressive subscription of 71.92 times, underlining massive investor interest in the stock.
The IPO comprised a fresh issue of shares worth ₹750 crore and an offer-for-sale of 18 lakh equity shares valued at ₹89.28 crore, bringing the total issue size to ₹839.38 crore. TruAlt plans to use the proceeds to broaden its biofuel operations, set up multi-feedstock facilities, reduce debt, and handle general corporate needs.
Headquartered in Bengaluru, TruAlt Bioenergy is a key player in the biofuels sector, primarily engaged in ethanol production. The company is increasing its focus on second-generation ethanol production through the use of surplus bagasse. Recognising the seasonal limitations of sugar-based raw materials like molasses and syrup, TruAlt is also investing in grain-based ethanol production to strengthen supply chain stability and reduce operational risks tied to fluctuations in raw material availability.
Read More: Upcoming IPOs in October 2025: 3 Key Mainboard Offerings to Watch!
Prior to listing, the IPO commanded a grey market premium of ₹85, suggesting a potential listing price of approximately ₹581. This implied a listing gain of around 17.14% from the issue price. Grey market trends had shown volatility over the past 14 sessions, with the premium peaking at ₹109.
On October 3, 2025, TruAlt Bioenergy share price opened at ₹545.40 on NSE, above the issue price of ₹496. During the day, it surged to ₹549.00 and dipped to ₹512.80. The stock is trading at ₹533.60 as of 1:01 PM. The stock registered a significant gain of 7.56%.
TruAlt Bioenergy’s successful market debut highlights its strong fundamentals and future potential in the biofuels segment. The oversubscription, combined with a premium listing, is a positive sign of investor confidence and sets the tone for its growth in the increasingly vital ethanol space.
Disclaimer: This blog has been written exclusively for educational purposes. The securities or companies mentioned are only examples and not recommendations. This does not constitute a personal recommendation or investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in securities are subject to market risks. Read all related documents carefully before investing.
Published on: Oct 3, 2025, 4:06 PM IST
Team Angel One
We're Live on WhatsApp! Join our channel for market insights & updates
Get the link to download the App
